Enhancing Medication-based Analgesia in Humans- STUDY 2
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pain
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Within-subject studyMasking: None (Open Label)Masking Description: Study drug administration will be concealed from all study staff and participants to prevent bias in outcomes.Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
This study will systematically evaluate whether a combination of pharmacotherapies can effectively alleviate chronic pain. Subjects will complete a screening session before completing 5 study sessions that will occur once weekly. Subjects will double-blind doses of study medications the morning of e...
This study will systematically evaluate whether a combination of pharmacotherapies can effectively alleviate chronic pain. Subjects will complete a screening session before completing 5 study sessions that will occur once weekly. Subjects will double-blind doses of study medications the morning of each experimental session, and will undergo standardized pain testing, as well as provide self-report ratings of drug effects, and cognitive tests.
Tracking Information
- NCT #
- NCT04036968
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Investigators
- Principal Investigator: Kelly E Dunn, PhD Johns Hopkins University Principal Investigator: Claudia Campbell, PhD Johns Hopkins University